Cargando…

Treating infections caused by carbapenemase-producing Enterobacterales (CPE): a pragmatic approach to antimicrobial stewardship on behalf of the UKCPA Pharmacy Infection Network (PIN)

The emergence of carbapenemase-producing Enterobacterales (CPE) as a major cause of invasive infection both within the UK and internationally poses a very real concern for all providers of healthcare. The burden of morbidity and mortality associated with CPE infections is well described. The need fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hughes, Stephen, Gilchrist, Mark, Heard, Katie, Hamilton, Ryan, Sneddon, Jacqueline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210165/ https://www.ncbi.nlm.nih.gov/pubmed/34223030 http://dx.doi.org/10.1093/jacamr/dlaa075

Ejemplares similares

Incidence and Time-to-Onset of Carbapenemase-Producing Enterobacterales (CPE) Infections in CPE Carriers: a Retrospective Cohort Study
por: Hoellinger, B., et al.
Publicado: (2022)

Risk Factors Associated with Carbapenemase-Producing Enterobacterales (CPE) Positivity in the Hospital Wastewater Environment
por: Park, Stacy C., et al.
Publicado: (2020)

837. Contamination of Hospital Drains by Carbapenemase-Producing Enterobacterales (CPE) in Ontario, Canada
por: Jamal, Alainna J, et al.
Publicado: (2020)

2468. The Genomic Epidemiology of Carbapenemase-Producing Enterobacterales (CPE) in Ontario, Canada, 2016
por: Jamal, Alainna J, et al.
Publicado: (2023)

Reflections on a national public health emergency response to carbapenemase-producing Enterobacterales (CPE)
por: Humphreys, Hilary, et al.
Publicado: (2022)

Characterization of Extensively Drug-Resistant (XDR) Carbapenemase-Producing Enterobacterales (CPE) in Canada from 2019 to 2020
por: Bartoszko, Jessica J., et al.
Publicado: (2022)

Knowledge, attitudes and self-reported practices of healthcare professionals on Carbapenemase Producing Enterobacterales (CPE): A cross sectional study
por: Paul Mathew, Shaini, et al.
Publicado: (2022)

Treatment of infections caused by carbapenemase-producing Enterobacterales
por: Íñigo, Melania, et al.
Publicado: (2022)

501. Risk of Infection in Persons Colonized with Carbapenemase-Producing Enterobacteriales (CPE) in Ontario, Canada
por: Faheem, Amna, et al.
Publicado: (2019)

SG-APSIC1118: Introduction of carbapenemase-producing Enterobacterales (CPE) in the aqueous environment of the newly built National Centre for Infectious Diseases (NCID) in Singapore
por: Ong, Chong Hui Clara, et al.
Publicado: (2023)

512. Healthcare-Acquired (HA) Carbapenemase-Producing Enterobacteriales (CPE) in Southern Ontario, Canada: To Whom Are We Transmitting CPE?
por: Jamal, Alainna, et al.
Publicado: (2019)

Audit and feedback as a tool to increase compliance with carbapenemase-producing Enterobacteriaceae (CPE) screening and decrease CPE transmission in the hospital
por: Ben Natan, Orna, et al.
Publicado: (2023)

Corrigendum: Carbapenemase-producing Enterobacteriaceae (CPE) isolated from pigs in China
por: Tong, Man-Ki, et al.
Publicado: (2019)

Implementation of an antimicrobial stewardship programme and reduction in carbapenemase-producing Enterobacterales in an Australian local health district
por: Cipko, Kimberly, et al.
Publicado: (2020)

2749. Impact of rapid carbapenemase identification on management of patients with carbapenem-resistant Enterobacterales infections
por: Burke, Elysia, et al.
Publicado: (2023)

Present and Future Perspectives on Therapeutic Options for Carbapenemase-Producing Enterobacterales Infections
por: Vrancianu, Corneliu Ovidiu, et al.
Publicado: (2021)

1186. Prevalence of Carbapenemase-Producing Enterobacteriaceae (CPE) in Hospital Drains in Southern Ontario
por: Jamal, Alainna, et al.
Publicado: (2018)

The Changing Epidemiology of Carbapenemase-Producing Enterobacterales
por: Hussein, Khetam, et al.
Publicado: (2022)

2165. Risk Factors for CPE Colonization in Household Contacts of CPE Colonized/Infected Patients
por: Farooqi, Lubna, et al.
Publicado: (2018)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
por: Lim, Fang Kang, et al.
Publicado: (2020)

1226. Two consecutive outbreaks of carbapenemase-producing enterobacteriaceae (CPE) in a pediatric hospital
por: Mor, Meirav, et al.
Publicado: (2022)

Evaluation of a novel procedure for rapid detection of carbapenemase-producing Enterobacteriaceae (CPE) using the LightMix(®) modular carbapenemase kits
por: Oviaño, Marina, et al.
Publicado: (2016)

Association Between Types of Carbapenemase and Clinical Outcomes of Infection Due to Carbapenem Resistance Enterobacterales
por: Pudpong, Korawan, et al.
Publicado: (2022)

Epidemiology and clinical characteristics of infection/colonization due to carbapenemase-producing Enterobacterales in neonatal patients
por: Wang, Jiansheng, et al.
Publicado: (2022)

Clostridium Perfringens Enterotoxin (CPE) and CPE-Binding Domain (c-CPE) for the Detection and Treatment of Gynecologic Cancers
por: Black, Jonathan D., et al.
Publicado: (2015)

Hospital effluent: A reservoir for carbapenemase-producing Enterobacterales?
por: Cahill, Niamh, et al.
Publicado: (2019)

Detection of Multidrug-Resistant Enterobacterales—From ESBLs to Carbapenemases
por: Noster, Janina, et al.
Publicado: (2021)

Dissemination of carbapenemase-producing Enterobacterales in the community of Rawalpindi, Pakistan
por: Habib, Amina, et al.
Publicado: (2022)

1228. Risk Factors for Contamination with Carbapenemase-Producing Enterobacteriales (CPE) in Exposed Hospital Drains in Ontario, Canada
por: Jamal, Alainna, et al.
Publicado: (2019)

Carbapenemase-Producing Enterobacteriaceae (CPE) Newborn Colonization in a Portuguese Neonatal Intensive Care Unit (NICU): Epidemiology and Infection Prevention and Control Measures
por: Almeida, Teresa L., et al.
Publicado: (2021)

503. Comparison of IMP Carbapenemase-Producing Enterobacteriaceae (CPE) and Non-Carbapenemase-Producing Enterobacteriaceae: A Multicenter Prospective Study of Clinical and Molecular Epidemiology in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2019)

Differences in the Distribution of Species, Carbapenemases, Sequence Types, Antimicrobial Heteroresistance and Mortality Rates Between Pediatric and Adult Carbapenemase-Producing Enterobacterales in Bloodstream Infections
por: Yu, Hanbing, et al.
Publicado: (2022)

Synergy between infection control and antimicrobial stewardship programs to control carbapenem-resistant Enterobacterales
por: Cornistein, Wanda, et al.
Publicado: (2023)

The acceptability of screening for Carbapenemase Producing Enterobacteriaceae (CPE): cross-sectional survey of nursing staff and the general publics’ perceptions
por: Currie, Kay, et al.
Publicado: (2018)

The potential of visible blue light (405 nm) as a novel decontamination strategy for carbapenemase-producing enterobacteriaceae (CPE)
por: Halstead, Fenella D., et al.
Publicado: (2019)

Identification and Preliminary Hierarchisation of Selected Risk Factors for Carbapenemase-Producing Enterobacteriaceae (CPE) Colonisation: A Prospective Study
por: Timler, Małgorzata, et al.
Publicado: (2023)

Risk factors in non‑surviving patients with infection with carbapenemase‑producing Enterobacterales strains in an intensive care unit
por: Vlad, Nicoleta-Dorina, et al.
Publicado: (2023)

Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis
por: Heard, Katie L, et al.
Publicado: (2021)

Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012–2018
por: Räisänen, Kati, et al.
Publicado: (2020)

Susceptibility of Clinical Enterobacterales Isolates With Common and Rare Carbapenemases to Mecillinam
por: Fuchs, Frieder, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ucno39d624m4fl3i2uam1d89m6